Alpine Global Management, LLC Cara Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$2.83 - $4.94 $96,259 - $168,029	34,014 New	34,014 $96,000
Q2 2023 Nov 21, 2023	BUY	$2.83 - $4.94 $96,259 - $168,029	34,014 New	34,014 $96,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $96,259 - $168,029	34,014 New	34,014 $96,000
Q1 2022 May 13, 2022	SELL	$9.94 - $12.65 $102,700 - $130,699	-10,332 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $123,880 - $187,422	10,332 New	10,332 $126,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.